ExpreS2ion Biotech Holding AB (EXPRS2) — Strategic Asset Allocation Index
ExpreS2ion Biotech Holding AB (EXPRS2) has a Strategic Asset Allocation Index of 1.3% as of December 2025. Strategic assets (PP&E of Skr465.00K plus long-term investments of Skr-) total Skr465.00K, measured against net assets of Skr35.69 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ExpreS2ion Biotech Holding AB balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ExpreS2ion Biotech Holding AB Strategic Asset Allocation Index (2016–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2025. As of December 2025, the index stands at 1.3%, representing strategic assets of Skr465.00K against net assets of Skr35.69 Million SEK. For live market cap and overall valuation, see market value of ExpreS2ion Biotech Holding AB.
Annual Strategic Asset Allocation Index for ExpreS2ion Biotech Holding AB (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for ExpreS2ion Biotech Holding AB from 2016 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is ExpreS2ion Biotech Holding AB's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.3% | Skr465.00K | Skr465.00K | Skr- | Skr35.69 Million | ▼ -1.1 pp |
| 2024 | 2.4% | Skr1.53 Million | Skr1.53 Million | Skr- | Skr64.42 Million | ▼ -0.3 pp |
| 2023 | 2.7% | Skr1.77 Million | Skr1.77 Million | Skr- | Skr65.36 Million | ▲ +1.8 pp |
| 2022 | 0.9% | Skr910.00K | Skr910.00K | Skr- | Skr103.33 Million | ▲ +0.0 pp |
| 2021 | 0.9% | Skr1.21 Million | Skr1.21 Million | Skr- | Skr140.35 Million | ▼ -0.5 pp |
| 2020 | 1.4% | Skr1.29 Million | Skr1.29 Million | Skr- | Skr94.55 Million | ▼ -10.6 pp |
| 2018 | 12.0% | Skr993.00K | Skr993.00K | Skr- | Skr8.30 Million | ▲ +2.6 pp |
| 2017 | 9.4% | Skr632.00K | Skr632.00K | Skr- | Skr6.74 Million | ▲ +4.1 pp |
| 2016 | 5.3% | Skr679.00K | Skr679.00K | Skr- | Skr12.88 Million | — |